ANTIDEPRESSANT ACTIVITY OF 2-HYDROXYDESIPRAMINE

被引：28

作者：

NELSON, JC ^{[1
]}

MAZURE, C ^{[1
]}

JATLOW, PI ^{[1
]}

机构：

[1] YALE UNIV,SCH MED,DEPT LAB MED,NEW HAVEN,CT 06510

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1988年 / 44卷 / 03期

关键词：

D O I：

10.1038/clpt.1988.151

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：283 / 288

页数：6

共 33 条

[1]

AMSTERDAM JD, 1985, ARCH GEN PSYCHIAT, V42, P361

[2] PRONOUNCED INHIBITION OF NORADRENALINE UPTAKE BY 10-HYDROXY-METABOLITES OF NORTRIPTYLINE [J].

BERTILSSON, L ;

MELLSTROM, B ;

SJOQVIST, F .

LIFE SCIENCES, 1979, 25 (15) :1285-1292

[3] DISPOSITION OF SINGLE ORAL DOSES OF E-10-HYDROXYNORTRIPTYLINE IN HEALTHY-SUBJECTS, WITH SOME OBSERVATIONS ON PHARMACODYNAMIC EFFECTS [J].

BERTILSSON, L ;

NORDIN, C ;

OTANI, K ;

RESUL, B ;

SCHEININ, M ;

SIWERS, B ;

SJOQVIST, F .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) :261-267

[4] STEADY-STATE PLASMA-CONCENTRATIONS OF CIS-10-OH AND TRANS-10-OH AMITRIPTYLINE METABOLITES [J].

BOCK, JL ;

GILLER, E ;

GRAY, S ;

JATLOW, P .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (05) :609-616

[5] DESIPRAMINE HYDROXYLATION - VARIABILITY AND EFFECT OF ANTI-PSYCHOTIC DRUGS [J].

BOCK, JL ;

NELSON, JC ;

GRAY, S ;

JATLOW, PI .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) :322-328

[6]

BOCK JL, 1983, CLIN PHARMACOL THER, V33, P190

[7] ANTIDEPRESSIVE EFFECT AND PHARMACOKINETICS OF AMITRIPTYLINE WITH CONSIDERATION OF UN-BOUND DRUG AND 10-HYDROXYNORTRIPTYLINE PLASMA-LEVELS [J].

BREYERPFAFF, U ;

GAERTNER, HJ ;

KREUTER, F ;

SCHAREK, G ;

BRINKSCHULTE, M ;

WIATR, R .

PSYCHOPHARMACOLOGY, 1982, 76 (03) :240-244

[8] DESIPRAMINE AND 2-HYDROXY-DESIPRAMINE PHARMACOKINETICS IN NORMAL VOLUNTEERS [J].

DEVANE, CL ;

SAVETT, M ;

JUSKO, WJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (01) :61-64

[9]

Guy W., 1976, ECDCEU ASSESSMENT MA

[10] A RATING SCALE FOR DEPRESSION [J].

HAMILTON, M .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62

← 1 2 3 4 →